Assertion: primary progressive ms | /r/HasProperty | ppms
Facets:
Source sentences:
text: Primary progressive MS (PPMS):
text: Primary progressive MS (PPMS)
text: One medication -- Ocrevus® (ocrelizumab) -- has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of primary-progressive MS (PPMS) as well as for relapsing forms of MS, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses).
text: The first DMT indicated for primary progressive MS (PPMS), ocrelizumab, suggests a potential role for B-cell therapy for progressive MS in younger patients with more active disease.
text: Around 15% of people with MS have primary progressive MS (PPMS).
text: Unlike relapsing forms of MS, primary-progressive MS (PPMS) is characterized by a fairly steady, gradual change in functional ability over time — most often related to walking — without any relapses.
text: Primary progressive MS (PPMS) affects about 10-15% of people diagnosed with MS.